Fatal Intoxication from 3,4-Methylenedioxyamphetamine
Alphonse Poklis, Mary Ann Mackell, Wk Drake
Journal of Forensic Sciences 1979 DOI: 10.1520/jfs10791j (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | MDA |
| Dose | 80 mg |
| Duration | Up to 8 h |
| Keywords | Amphetamine Methaqualone Electrocution Designer drug Poison control Hallucinogen Forensic toxicology Pharmacology Anesthesia |
| Citations | 25 |
| Key findings | MDA acts as a CNS stimulant with amphetamine-like sympathomimetic activity and mescaline-like psychopharmacological effects, producing perceptual distortions at 80 mg and hallucinations at high doses. |
Abstract
Abstract 3,4-Methylenedioxyamphetamine (MDA) is a potent central nervous system (CNS) stimulant chemically and pharmacologically related to amphetamine and mescaline [1–3] (Fig. 1). The phenylisopropylamine portion of the molecule gives MDA marked sympathomimetic activity similar to amphetamine demonstrated by peripheral vasoconstriction, tachycardia, pupillary dilation, and effects on other smooth muscles. The CNS stimulatory effects of MDA also mimic those of amphetamine, and at high doses convulsions, hyperthermia, and behavioral changes may occur [4]. The 3,4-methyleneoxy group on the phenyl portion of the molecule gives MDA psychopharmacological properties similar to those of mescaline. At an apparent threshold dose of 80 mg, MDA causes marked perceptional distortions that begin approximately 60 min after oral ingestion and last up to 8 h [5]. Subjective effects include intensification of feelings, a facilitation of self-insight, and an overwhelming desire to communicate and relate to other people [6]. At high doses, hallucinations may appear.